Abridge, a generative AI platform for clinical conversations, has raised $250 million in a Series D funding round co-led by Elad Gil and IVP, with contributions from several notable investors. The platform transforms medical conversations into billable documentation at the point of care, aiming to alleviate administrative burdens and clinician burnout while enhancing patient experiences. Abridge integrates with EHRs, supports over 28 languages and 50 specialties, and is utilized in various care settings. The funding will advance the company’s AI capabilities and commercial growth, including partnerships with Epic and Sutter Health to improve clinical documentation processes.